Impact of residential medication management reviews on anticholinergic burden in aged care residents

References

• McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163-84.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Residential aged care in Australia 2010–11: a statistical overview. Australian Government, 2012. Available at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737422896 [Accessed 23 November 2014]
   Google Scholar
• Courtney MD, Edwards HE, Joyce S, et al. Quality of life measures for residents of aged care facilities: a literature review. Australas J Ageing 2003;22:58-64.
   Web of Science ®Google Scholar
• Falconer M, O'Neill D. Profiling disability within nursing homes: a census-based approach. Age Ageing 2007;36:209-13.
   PubMed Web of Science ®Google Scholar
• Walley T, Scott AK. Prescribing in the elderly. Postgrad Med J 1995;71:466-71.
   PubMed Web of Science ®Google Scholar
• Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 2009;4:225-33.
   PubMed Web of Science ®Google Scholar
• Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 2011;59:1477-83.
   PubMed Web of Science ®Google Scholar
• Sittironnarit G, Ames D, Bush AI, et al. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord 2011;31:173-8.
   PubMed Web of Science ®Google Scholar
• Narayan SW, Hilmer SN, Horsburgh S, Nishtala PS. Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging 2013;30:927-34.
   PubMed Web of Science ®Google Scholar
• Uusvaara J, Pitkala KH, Kautiainen H, et al. Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study. Drugs Aging 2013;30:177-82.
   PubMed Web of Science ®Google Scholar
• Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001;161:1099-105.
   PubMed Web of Science ®Google Scholar
• Kumpula EK, Bell JS, Soini H, Pitkala KH. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol 2011;51:256-63.
   PubMed Web of Science ®Google Scholar
• Morgan TK, Williamson M, Pirotta M, et al. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust 2012;196:50-3.
   PubMed Web of Science ®Google Scholar
• Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008;56:1333-41.
   PubMed Web of Science ®Google Scholar
• Mangoni AA, van Munster BC, Woodman RJ, de Rooij SE. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 2013;21:785-93.
   PubMed Web of Science ®Google Scholar
• Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62(Suppl 21):11-14.
   PubMed Web of Science ®Google Scholar
• Bostock CV, Soiza RL, Mangoni AA. Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people. Expert Rev Clin Pharmacol 2010;3:441-52.
   PubMedGoogle Scholar
• Wilson NM, Hilmer SN, March LM, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011;59:875-80.
   PubMed Web of Science ®Google Scholar
• Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the ageing brain: a review and practical application. Aging Health 2008;4:311-20.
   Google Scholar
• Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455-9.
   PubMed Web of Science ®Google Scholar
• Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008;168:508-13.
   PubMed Web of Science ®Google Scholar
• Carnahan RM, Lund BC, Perry PJ, et al. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006;46:1481-6.
   PubMed Web of Science ®Google Scholar
• Ehrt U, Broich K, Larsen JP, et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. J Neurol Neurosurg Psychiatry 2010;81:160-5.
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007;167:781-7
   PubMed Web of Science ®Google Scholar
• Nishtala PS, Fois RA, McLachlan AJ, et al. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J Clin Pharmacol 2009;49:1176-84.
   PubMed Web of Science ®Google Scholar
• Gheewala PA, Peterson GM, Curtain CM, et al. Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities. Drugs Aging 2014;31:825-35
   PubMed Web of Science ®Google Scholar
• Nishtala PS, McLachlan AJ, Bell JS, Chen TF. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract 2011;17:97-103.
   PubMed Web of Science ®Google Scholar
• Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001;51:257-65.
   PubMed Web of Science ®Google Scholar
• Nishtala PS, Hilmer SN, McLachlan AJ, et al. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging 2009;26:677-86.
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother 2010;44:1725-32.
   PubMed Web of Science ®Google Scholar
• He Z, Ball PA. Can medication management review reduce anticholinergic burden (ACB) in the elderly? Encouraging results from a theoretical model. Int Psychogeriatr 2013;25:1425-31.
   PubMed Web of Science ®Google Scholar
• Kersten H, Molden E, Tolo IK, et al. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 2013;68:271-8.
   PubMed Web of Science ®Google Scholar
• Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 2013;69:1485-96.
   PubMed Web of Science ®Google Scholar
• Castelino RL, Hilmer SN, Bajorek BV, et al. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging 2010;27:135-48.
   PubMed Web of Science ®Google Scholar
• Campbell NL, Boustani MA, Lane KA, et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 2010;75:152-9.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Mehta S, Sherer JT, Aparasu RR. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey. Drugs Aging 2010;27:987-97.
   PubMed Web of Science ®Google Scholar
• Kalisch Ellett L, Pratt N, Ramsay E, et al. Multiple anticholinergic medicine use and risk of hospital admission for confusion or dementia. National Medicines Symposium – Medicines in Health, Brisbane, 21–23 May 2014
   Google Scholar